Summary Keywords topiramate, migraine, oxidative stress, neurogenic inflammation, ferroptosis Citation Chen Q-W, Meng R-T and Ko C-Y (2024) Modulating oxidative stress and neurogenic inflammation: the role of topiramate in migraine treatment
Down-regulation of the K + Cl co-transporter KCC2 has been reported in multiple studies 3,4,5,6,7
This process helps determine whether peptide therapy such as GHK-Cu is clinically appropriate and identifies any potential contraindications or risk factors before initiating treatment
I honestly cannot express how much my skin has changed in the past year
In vitro studies, preclinical studies, retrospective studies and randomized clinical trials performed in Europe and the USA were included
doi: 10.1042/bj3320097